Cargando…

267. Therapeutic Management of Bacterial Brain Abscess: An Overview of Diagnosis and Outcomes

BACKGROUND: We describe and compare the clinical, diagnostic evaluation and outcomes of patients who underwent therapeutic management for pyogenic brain abscess. METHODS: We retrospectively reviewed adults who presented with pyogenic brain abscess from January 1, 2009 through June 30, 2020. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Campioli, Cristina G Corsini, Go, John Raymond U, O’Horo, John C, Sohail, M Rizwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644861/
http://dx.doi.org/10.1093/ofid/ofab466.469
_version_ 1784610183865958400
author Campioli, Cristina G Corsini
Go, John Raymond U
O’Horo, John C
Sohail, M Rizwan
Sohail, M Rizwan
author_facet Campioli, Cristina G Corsini
Go, John Raymond U
O’Horo, John C
Sohail, M Rizwan
Sohail, M Rizwan
author_sort Campioli, Cristina G Corsini
collection PubMed
description BACKGROUND: We describe and compare the clinical, diagnostic evaluation and outcomes of patients who underwent therapeutic management for pyogenic brain abscess. METHODS: We retrospectively reviewed adults who presented with pyogenic brain abscess from January 1, 2009 through June 30, 2020. RESULTS: 231 patients were identified during the study period. Sixty-one (26.4%) patients received antibiotic therapy alone, and 170 (73.6%) had a combination of antibiotic therapy and surgical intervention. The median age for the medical and combined therapy group was 59 years and 58 years, respectively. Patients who received medical treatment had a higher prevalence of infective endocarditis than those who received combined therapy (6.6% vs. 0.6%; P=0.005). The medical therapy group was more likely to have brain MRI and cranial CT than the patients with combined therapy (75.4% vs. 63.5%; P=0.041). Midline shift (11.5% vs. 31.2%; P=0.002), a single (21% vs. 83%; P=0.001) and greater size (1.4 cm vs. 2.5 cm; P=0.007) brain abscess was significant when comparing medical vs. surgically managed abscess. Stereotactic surgical technique was the preferred diagnostic approach for the medical group (65.6% vs. 46.5%; P=0.010), and excision/craniotomy for the combined group (31.1% vs. 53.5%; P=0.002). Streptococcus viridans group was the predominant organism (32.8% and 25.9%; P=0.30). Compared to those who received combined therapy, patients with medical therapy alone were most likely to receive cephalosporin (72.1% vs. 41.2%; P=< 0.0001), vancomycin (23% vs. 12.4%; P=0.047) and metronidazole (27.9% vs. 14.7%; P=0.022). In both groups, median duration of antimicrobial therapy was 42 days (P=0.12). Patients with medical therapy alone had a higher mortality rate (18% vs. 7.1%; p=0.014) but less neurologic sequelae (21.3% vs. 30.6%; P=0.16) compared with combined therapy. Medical Management. Organism isolated in the medical management group [Image: see text] Combined Management. Organism isolated in the combined management group [Image: see text] Demographic and Clinical Characteristics of Patients with Brain Abscess who Underwent Therapeutic Management [Image: see text] CONCLUSION: Most patients with pyogenic brain abscess had no identified risk factors, and brain MRI and cranial CT were the diagnostic imaging modalities of choice. Compared to those who received medical therapy alone, patients with combined treatment had a single and greater size fluid collection with the presence of midline shift. A prompt combined surgical and medical approach with prolonged antimicrobial therapy can cure the infection. Outcomes of Patients with Bacterial Brain Abscess [Image: see text] Radiologic and Surgical Diagnosis of Patient with Brain Abscess who Underwent Therapeutic Management [Image: see text] DISCLOSURES: John C. O’Horo, Sr., MD, MPH, Bates College and Elsevier Inc (Consultant) M. Rizwan Sohail, MD, Medtronic Inc., Philips, and Aziyo Biologics, Inc (Consultant) M. Rizwan Sohail, MD, Aziyo Biologics (Individual(s) Involved: Self): Consultant; Philips (Individual(s) Involved: Self): Consultant
format Online
Article
Text
id pubmed-8644861
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86448612021-12-06 267. Therapeutic Management of Bacterial Brain Abscess: An Overview of Diagnosis and Outcomes Campioli, Cristina G Corsini Go, John Raymond U O’Horo, John C Sohail, M Rizwan Sohail, M Rizwan Open Forum Infect Dis Poster Abstracts BACKGROUND: We describe and compare the clinical, diagnostic evaluation and outcomes of patients who underwent therapeutic management for pyogenic brain abscess. METHODS: We retrospectively reviewed adults who presented with pyogenic brain abscess from January 1, 2009 through June 30, 2020. RESULTS: 231 patients were identified during the study period. Sixty-one (26.4%) patients received antibiotic therapy alone, and 170 (73.6%) had a combination of antibiotic therapy and surgical intervention. The median age for the medical and combined therapy group was 59 years and 58 years, respectively. Patients who received medical treatment had a higher prevalence of infective endocarditis than those who received combined therapy (6.6% vs. 0.6%; P=0.005). The medical therapy group was more likely to have brain MRI and cranial CT than the patients with combined therapy (75.4% vs. 63.5%; P=0.041). Midline shift (11.5% vs. 31.2%; P=0.002), a single (21% vs. 83%; P=0.001) and greater size (1.4 cm vs. 2.5 cm; P=0.007) brain abscess was significant when comparing medical vs. surgically managed abscess. Stereotactic surgical technique was the preferred diagnostic approach for the medical group (65.6% vs. 46.5%; P=0.010), and excision/craniotomy for the combined group (31.1% vs. 53.5%; P=0.002). Streptococcus viridans group was the predominant organism (32.8% and 25.9%; P=0.30). Compared to those who received combined therapy, patients with medical therapy alone were most likely to receive cephalosporin (72.1% vs. 41.2%; P=< 0.0001), vancomycin (23% vs. 12.4%; P=0.047) and metronidazole (27.9% vs. 14.7%; P=0.022). In both groups, median duration of antimicrobial therapy was 42 days (P=0.12). Patients with medical therapy alone had a higher mortality rate (18% vs. 7.1%; p=0.014) but less neurologic sequelae (21.3% vs. 30.6%; P=0.16) compared with combined therapy. Medical Management. Organism isolated in the medical management group [Image: see text] Combined Management. Organism isolated in the combined management group [Image: see text] Demographic and Clinical Characteristics of Patients with Brain Abscess who Underwent Therapeutic Management [Image: see text] CONCLUSION: Most patients with pyogenic brain abscess had no identified risk factors, and brain MRI and cranial CT were the diagnostic imaging modalities of choice. Compared to those who received medical therapy alone, patients with combined treatment had a single and greater size fluid collection with the presence of midline shift. A prompt combined surgical and medical approach with prolonged antimicrobial therapy can cure the infection. Outcomes of Patients with Bacterial Brain Abscess [Image: see text] Radiologic and Surgical Diagnosis of Patient with Brain Abscess who Underwent Therapeutic Management [Image: see text] DISCLOSURES: John C. O’Horo, Sr., MD, MPH, Bates College and Elsevier Inc (Consultant) M. Rizwan Sohail, MD, Medtronic Inc., Philips, and Aziyo Biologics, Inc (Consultant) M. Rizwan Sohail, MD, Aziyo Biologics (Individual(s) Involved: Self): Consultant; Philips (Individual(s) Involved: Self): Consultant Oxford University Press 2021-12-04 /pmc/articles/PMC8644861/ http://dx.doi.org/10.1093/ofid/ofab466.469 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Campioli, Cristina G Corsini
Go, John Raymond U
O’Horo, John C
Sohail, M Rizwan
Sohail, M Rizwan
267. Therapeutic Management of Bacterial Brain Abscess: An Overview of Diagnosis and Outcomes
title 267. Therapeutic Management of Bacterial Brain Abscess: An Overview of Diagnosis and Outcomes
title_full 267. Therapeutic Management of Bacterial Brain Abscess: An Overview of Diagnosis and Outcomes
title_fullStr 267. Therapeutic Management of Bacterial Brain Abscess: An Overview of Diagnosis and Outcomes
title_full_unstemmed 267. Therapeutic Management of Bacterial Brain Abscess: An Overview of Diagnosis and Outcomes
title_short 267. Therapeutic Management of Bacterial Brain Abscess: An Overview of Diagnosis and Outcomes
title_sort 267. therapeutic management of bacterial brain abscess: an overview of diagnosis and outcomes
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644861/
http://dx.doi.org/10.1093/ofid/ofab466.469
work_keys_str_mv AT campiolicristinagcorsini 267therapeuticmanagementofbacterialbrainabscessanoverviewofdiagnosisandoutcomes
AT gojohnraymondu 267therapeuticmanagementofbacterialbrainabscessanoverviewofdiagnosisandoutcomes
AT ohorojohnc 267therapeuticmanagementofbacterialbrainabscessanoverviewofdiagnosisandoutcomes
AT sohailmrizwan 267therapeuticmanagementofbacterialbrainabscessanoverviewofdiagnosisandoutcomes
AT sohailmrizwan 267therapeuticmanagementofbacterialbrainabscessanoverviewofdiagnosisandoutcomes